Trial Outcomes & Findings for A Comparison Between Conventional and Waveform-Confirmed Loss-of-Resistance for Thoracic Epidural Blocks (NCT NCT02479763)

NCT ID: NCT02479763

Last Updated: 2016-02-22

Results Overview

Fifteen minutes after the LA injection, a blinded observer will apply ice to the T1-L4 dermatomes and assess the epidural block. The criterion standard for success will be the presence of an epidural block (defined as a block to ice in at least 2 dermatomes bilaterally). If the operators cannot thread the catheter after 2 attempts, epidural blocks will considered failures.

Recruitment status

COMPLETED

Study phase

PHASE2/PHASE3

Target enrollment

106 participants

Primary outcome timeframe

up to 15 minutes after the procedure

Results posted on

2016-02-22

Participant Flow

Participant milestones

Participant milestones
Measure
Conventional Loss-of-resistance
Conventional loss-of-resistance: Using tactile feeling to identify thoracic epidural space
Waveform-confirmed Loss-of-resistance
Waveform-confirmed loss-of-resistance: Using waveform analysis to confirm thoracic epidural space
Overall Study
STARTED
53
53
Overall Study
COMPLETED
50
50
Overall Study
NOT COMPLETED
3
3

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

A Comparison Between Conventional and Waveform-Confirmed Loss-of-Resistance for Thoracic Epidural Blocks

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Conventional Loss-of-resistance
n=50 Participants
Conventional loss-of-resistance: Using tactile feeling to identify thoracic epidural space
Waveform-confirmed Loss-of-resistance
n=50 Participants
Waveform-confirmed loss-of-resistance: Using waveform analysis to confirm thoracic epidural space
Total
n=100 Participants
Total of all reporting groups
Age, Continuous
61.4 years
STANDARD_DEVIATION 11.0 • n=99 Participants
61.1 years
STANDARD_DEVIATION 11.8 • n=107 Participants
61.3 years
STANDARD_DEVIATION 11.4 • n=206 Participants
Sex: Female, Male
Female
16 Participants
n=99 Participants
20 Participants
n=107 Participants
36 Participants
n=206 Participants
Sex: Female, Male
Male
34 Participants
n=99 Participants
30 Participants
n=107 Participants
64 Participants
n=206 Participants
BMI (kg/m^2), Continuous
25.5 kg/m^2
STANDARD_DEVIATION 4.4 • n=99 Participants
24.6 kg/m^2
STANDARD_DEVIATION 3.7 • n=107 Participants
25.1 kg/m^2
STANDARD_DEVIATION 4.1 • n=206 Participants
American Society of Anesthesiologists (ASA) physical status, Categorical
Class I; A normal healthy patient
3 participants
n=99 Participants
9 participants
n=107 Participants
12 participants
n=206 Participants
American Society of Anesthesiologists (ASA) physical status, Categorical
Class II; A patient with mild systemic disease
21 participants
n=99 Participants
23 participants
n=107 Participants
44 participants
n=206 Participants
American Society of Anesthesiologists (ASA) physical status, Categorical
Class III; A patient with severe systemic disease
26 participants
n=99 Participants
18 participants
n=107 Participants
44 participants
n=206 Participants

PRIMARY outcome

Timeframe: up to 15 minutes after the procedure

Fifteen minutes after the LA injection, a blinded observer will apply ice to the T1-L4 dermatomes and assess the epidural block. The criterion standard for success will be the presence of an epidural block (defined as a block to ice in at least 2 dermatomes bilaterally). If the operators cannot thread the catheter after 2 attempts, epidural blocks will considered failures.

Outcome measures

Outcome measures
Measure
Conventional Loss-of-resistance
n=50 Participants
Waveform-confirmed Loss-of-resistance
n=50 Participants
Waveform-confirmed loss-of-resistance: Using waveform analysis to confirm thoracic epidural space
Percentage of Patients With Successful Epidural Blocks
76 percentage of patients
98 percentage of patients

Adverse Events

Conventional Loss-of-resistance

Serious events: 0 serious events
Other events: 2 other events
Deaths: 0 deaths

Waveform-confirmed Loss-of-resistance

Serious events: 0 serious events
Other events: 2 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Conventional Loss-of-resistance
n=50 participants at risk
Waveform-confirmed Loss-of-resistance
n=50 participants at risk
Waveform-confirmed loss-of-resistance: Using waveform analysis to confirm thoracic epidural space
Nervous system disorders
Transient self-resolving paresthesia
0.00%
0/50
4.0%
2/50 • Number of events 2
Vascular disorders
Vascular breach
4.0%
2/50 • Number of events 2
0.00%
0/50

Additional Information

Dr. De QH Tran

Montreal General Hospital

Phone: 514-934-1934

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place